Bain Capital Life Sciences
Biotech Investor · 5 portfolio companies
Portfolio
5
Combined Value
$4.7B
Focus Areas
8
Top Stage
Phase 3
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| NewAmsterdam Pharma | $4.7B |
| Areteia Therapeutics | — |
| JenaValve | — |
| Cardurion Pharmaceuticals | — |
| Aiolos Bio | — |